Periodontal regeneration: from historical foundations to modern clinical challenges

The degradation of the periodontal attachment apparatus constitutes a major challenge, threatening the stability of the dentition and the viability of implant sites. This exhaustive review analyzes the transition of regenerative surgery, moving from simple clinical observation to science-driven tissue engineering. The objective is clear: to recreate a micro-environment favorable to the restoration of the alveolar bone, cementum, and periodontal ligament.

The authors place this issue within a historical perspective, recalling milestones such as Van Meekren's first xenograft (1632), Macewen's pioneering allograft (1881), and the theorization of "creeping substitution" by Marchand (1901). The identification of bone morphogenetic proteins (BMPs) by Marshall Urist in 1965 sealed the paradigm of osteoinduction, which is central to our current therapies.

This synthesis examines the comparative efficacy of biomaterials — autografts, allografts, xenografts, and synthetic substitutes — based on the biological triad (osteogenesis, induction, conduction). The review suggests that successful reconstruction relies on the alignment between defect morphology, graft immobilization, and the exploitation of the bone induction cascade to achieve true histological regeneration rather than simple tissue repair.

Methodology

This study is a comprehensive narrative review that synthesizes the historical evolution, biological foundations, and clinical efficacy of bone substitute materials in periodontology. The methodology is based on a detailed synthesis of anatomical, physiological, and clinical literature, integrating both historical milestones and contemporary systematic reviews.

The analysis protocol has made it possible to classify and evaluate biomaterials according to four main categories:

• Autografts: Analyzed as the gold standard for their osteogenic, osteoinductive, and osteoconductive properties.
• Allografts: Evaluation of demineralized freeze-dried bone allograft (DFDBA) and mineralized bone (FDBA).
• Xenografts: Study of bovine-derived (BDX) and coral materials for their structural scaffolding properties.
• Alloplastic materials: Analysis of hydroxyapatite, β-tricalcium phosphate (β-TCP), calcium sulfate, and bioactive glasses, including their synergy with growth factors such as PDGF-BB.

The clinical performance evaluation focused on two primary endpoints: clinical attachment level (CAL) gain and probing depth (PD) reduction. The methodological analysis dates back to the first documented evidence from 1632 and extends to modern tissue engineering approaches for treating intrabony defects and furcation involvements.

Comparative performance of bone graft biomaterials

This review synthesizes the clinical efficacy of the different classes of grafts used in periodontal regeneration. Autogenous bone remains the "gold standard" thanks to its unique biological triad: osteogenesis, osteoinduction, and osteoconduction. Modern substitutes, however, show predictable results in terms of clinical attachment level (CAL) gain and probing depth (PD) reduction, particularly when combined with growth factors such as PDGF-BB.

Historical data and critical success factors

The analysis of the evolution of techniques highlights the constant superiority of autogenous grafts over the long term. As early as 1954, the work of Converse and Campbell demonstrated clinical failure rates three times higher for homografts compared to autogenous bone. Furthermore, freezing protocols have been validated by ultrastructural analysis for their ability to effectively destroy malignant cells within the graft (Wang et al., 1980).

In contemporary clinical practice, membrane or graft exposure is reported as the most frequent complication. The authors of this review specify that achieving true histological regeneration, rather than simple repair, depends on three fundamental pillars:

• Absolute graft immobilization: essential for preserving the bone induction cascade.
• Soft tissue coverage: hermetic protection is imperative for the viability of the site.
• Biomaterial selection: it must be specifically dictated by the morphology of the bone defect.

Analysis of periodontology reconstruction strategies

This review highlights that periodontal regeneration is no longer limited to simple filling, but is part of precise biological engineering. Autogenous bone maintains its "gold standard" status thanks to its unique ability to combine osteogenesis, osteoinduction, and osteoconduction. However, the compiled data show that alternatives — allografts (FDBA, DFDBA), xenografts, and synthetic materials — offer highly predictable clinical attachment level (CAL) gains and probing depth (PD) reductions, provided that fundamental biological principles are respected.

A major point emerges: the efficacy of alloplastic materials (hydroxyapatite, β-TCP, bioactive glasses) is significantly boosted when combined with growth factors such as PDGF-BB. This synergy transforms a simple osteoconductive scaffold into an active device capable of stimulating the bone induction cascade. Nevertheless, the authors reiterate that clinical success is not guaranteed by the choice of material alone; it intrinsically depends on the defect morphology and surgical rigor, notably the absolute immobilization of the graft and total soft tissue coverage.

The limitations of this review lie in the variability of the results depending on the initial size of the bone defects. Although modern biomaterials are efficient, their resorption remains time-dependent and their effectiveness decreases when faced with excessive bone loss. The practitioner must therefore decide between the superior regenerative potential of autografts and the reduction in morbidity offered by substitutes.

Conclusion

The success of periodontology reconstruction relies on the creation of a micro-environment conducive to true histological regeneration rather than simple tissue repair.

Summary of results

This systematic review, synthesizing clinical and historical data, confirms that autogenous bone remains the gold standard thanks to its complete biological triad. It reports the efficacy of allografts (FDBA, DFDBA) and coral xenografts, while highlighting that alloplastic substitutes (HA, β-TCP) combined with PDGF-BB allow for predictable clinical attachment gains.

In concrete terms, for the practitioner:

• Adapt the material to the defect: The selection of your biomaterial must be dictated by the morphology of the bone defect in order to ensure the space maintenance and structural stability necessary for reconstruction.
• Demand absolute stability: Clinical success relies on the strict immobilization of the graft and hermetic soft tissue coverage to transform simple repair into true histological regeneration.
• Optimize bone induction: To mitigate donor site morbidity, prioritize the use of synthetic substitutes coupled with biological mediators to effectively trigger the bone neoformation cascade.

Lexicon of periodontology regeneration

Osteogenesis: The exclusive "super-power" of autogenous bone. The graft does not merely serve as a scaffold; it brings its own workers (living osteoblasts) to the site to directly initiate the synthesis of new bone tissue.

Osteoinduction: The ability of a material to recruit and program host stem cells to transform into bone cells, a biological cascade driven by bone morphogenetic proteins (BMPs).

Osteoconduction: The role of an architectural scaffold. The biomaterial (often synthetic or xenogeneic) provides a passive physical structure allowing colonization by the patient's blood vessels and bone cells.

Creeping substitution: Concept defined by Marchand in 1901 describing the progressive replacement of the graft by the patient's newly formed bone. The material serves as a temporary matrix before being fully metabolized and replaced by vital tissue.

DFDBA (Decalcified Freeze-Dried Bone Allograft): Decalcified freeze-dried bone allograft. This chemical treatment exposes endogenous matrix proteins, providing the material with superior osteoinductive potential to promote true histological regeneration.

BMP (Bone Morphogenetic Proteins): The "switch" molecules of bone biology identified by Marshall Urist in 1965. They orchestrate the cellular differentiation required to transition from simple scar repair to organized tissue reconstruction.

Information intended for healthcare professionals. This content may contain errors or truncated summaries. We recommend always verifying with the original source article. Delynov disclaims all responsibility regarding the use of this information. This document is not intended for patients or the general public.